Risk factors for cervical precancer detection among previously unscreened HIV-infected women in Western Kenya

International Journal of Cancer

Volumn 134, Issue 3, 2014, Pages 740-745

  Huchko, Megan J ^a   Leslie, Hannah ^b   Sneden, Jennifer ^a   Maloba, May ^c   Abdulrahim, Naila ^c   Bukusi, Elizabeth A ^c   Cohen, Craig R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

Author keywords

cervical cancer; cervical intraepithelial neoplasia; HIV; Kenya

Indexed keywords

ACETIC ACID; CD4 ANTIGEN; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; CANCER RISK; CANCER SCREENING; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; KENYA; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; ORAL CONTRACEPTIVE USE; PRIORITY JOURNAL; RISK FACTOR; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU;

EID: 84888009830     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28401     Document Type: Article

References (25)

1. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-917.
2. UNAIDS. Global Report: UNAIDS Report on the Global AIDS Epidemic 2010. Geneva.
3. De Vuyst H, Gichangi P, Estambale B, et al. Human papillomavirus types in women with invasive cervical carcinoma by HIV status in Kenya. Int J Cancer 2008; 122: 244-6.
4. Chaturvedi AK, Madeleine MM, Biggar RJ, et al. Risk of human papillomavirus-associated cancers among persons with AIDS. J Natl Cancer Inst 2009; 101: 1120-30.
5. Denny L, Boa R, Williamson AL, et al. Human papillomavirus infection and cervical disease in human immunodeficiency virus-1-infected women. Obstet Gynecol 2008; 111: 1380-7.
6. World Health Organization. Global HIV/AIDS response: progress report 2011. Key facts on HIV epidemic and progress in regions and countries in 2010. Sub-Saharan Africa: World Health Organization; 2011.
7. Bratcher LF, Sahasrabuddhe VV,. The impact of antiretroviral therapy on HPV and cervical intraepithelial neoplasia: current evidence and directions for future research. Infect Agent Cancer 2010; 5: 8.
8. Franceschi S, Lise M, Clifford GM, et al. Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study. Br J Cancer 2010; 103: 416-22.
9. De Vuyst H, Mugo NR, Chung MH, et al. Prevalence and determinants of human papillomavirus infection and cervical lesions in HIV-positive women in Kenya. Br J Cancer 2012; 107: 1624-30.
10. Parham GP, Sahasrabuddhe VV, Mwanahamuntu MH, et al. Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia. Gynecol Oncol 2006; 103: 1017-22.
11. Firnhaber C, Mayisela N, Mao L, et al. Validation of cervical cancer screening methods in HIV positive women from Johannesburg South Africa. PLoS One 2013; 8: e53494.
12. Mwanahamuntu MH, Sahasrabuddhe VV, Kapambwe S, et al. Advancing cervical cancer prevention initiatives in resource-constrained settings: insights from the Cervical Cancer Prevention Program in Zambia. PLoS Med 2011; 8: e1001032.
13. Moon TD, Silva-Matos C, Cordoso A, et al. Implementation of cervical cancer screening using visual inspection with acetic acid in rural Mozambique: successes and challenges using HIV care and treatment programme investments in Zambezia Province. J Int AIDS Soc 2012; 15: 17406.
14. Akinwuntan AL, Adesina OA, Okolo CA, et al. Correlation of cervical cytology and visual inspection with acetic acid in HIV-positive women. J Obstet Gynaecol 2008; 28: 638-41.
15. Memiah P, Mbuthia W, Kiiru G, et al. Prevalence and risk factors associated with precancerous cervical cancer lesions among HIV-infected women in resource-limited settings. AIDS Res Treat 2012; 2012: 953743.
16. Lewis Kulzer J, Penner JA, Marima R, et al. Family model of HIV care and treatment: a retrospective study in Kenya. J Int AIDS Soc 2012; 15: 8.
17. Walker P, Dexeus S, De Palo G, et al. International terminology of colposcopy: an updated report from the International Federation for Cervical Pathology and Colposcopy. Obstet Gynecol 2003; 101: 175-7.
18. Cremer M, Conlisk E, Maza M, et al. Adequacy of visual inspection with acetic acid in women of advancing age. Int J Gynaecol Obstet 2011; 113: 68-71.
19. Biggar RJ, Chaturvedi AK, Goedert JJ, et al. AIDS-related cancer and severity of immunosuppression in persons with AIDS. J Natl Cancer Inst 2007; 99: 962-72.
20. Heard I, Potard V, Costagliola D,. Limited impact of immunosuppression and HAART on the incidence of cervical squamous intraepithelial lesions in HIV-positive women. Antivir Ther 2006; 11: 1091-6.
21. Adler DH, Kakinami L, Modisenyane T, et al. Increased regression and decreased incidence of human papillomavirus-related cervical lesions among HIV-infected women on HAART. AIDS 2012; 26: 1645-52.
22. Soncini E, Zoncada A, Condemi V, et al. Reduction of the risk of cervical intraepithelial neoplasia in HIV-infected women treated with highly active antiretroviral therapy. Acta Biomed 2007; 78: 36-40.
23. Longatto-Filho A, Hammes LS, Sarian LO, et al. Hormonal contraceptives and the length of their use are not independent risk factors for high-risk HPV infections or high-grade CIN. Gynecol Obstet Invest 2011; 71: 93-103.
24. Roset Bahmanyar E, Paavonen J, Naud P, et al. Prevalence and risk factors for cervical HPV infection and abnormalities in young adult women at enrolment in the multinational PATRICIA trial. Gynecol Oncol 2012; 127: 440-50.
25. Samir R, Asplund A, Tot T, et al. Oral contraceptive and progestin-only use correlates to tissue tumor marker expression in women with cervical intraepithelial neoplasia. Contraception 2012; 85: 288-93.